Switch theme
Sign up to access all valuation multiples
Bangkok Dusit Medical Services PCL operates a network of hospitals throughout Thailand under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments namely, hospital operations and other businesses that support hospital business such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, assets management for healthcare business, accounting services, technology and information services, training business and insurance broker. The company's hospital operations generate the vast majority of its revenue.
1969
56.0K+
LTM Revenue $3.2B
LTM EBITDA $777M
$11.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Bangkok Dusit Medical Services has a last 12-month revenue of $3.2B and a last 12-month EBITDA of $777M.
In the most recent fiscal year, Bangkok Dusit Medical Services achieved revenue of $3.2B and an EBITDA of $790M.
Bangkok Dusit Medical Services expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Bangkok Dusit Medical Services valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $3.0B | $3.2B | XXX | XXX | XXX |
| Gross Profit | $987M | $1.1B | XXX | XXX | XXX |
| Gross Margin | 33% | 35% | XXX | XXX | XXX |
| EBITDA | $736M | $790M | XXX | XXX | XXX |
| EBITDA Margin | 25% | 25% | XXX | XXX | XXX |
| Net Profit | $370M | $422M | XXX | XXX | XXX |
| Net Margin | 12% | 13% | XXX | XXX | XXX |
| Net Debt | $98.8M | $79.5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Bangkok Dusit Medical Services's stock price is THB 23 (or $1).
Bangkok Dusit Medical Services has current market cap of THB 369B (or $10.8B), and EV of THB 378B (or $11.1B).
See Bangkok Dusit Medical Services trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $11.1B | $10.8B | XXX | XXX | XXX | XXX | $0.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Bangkok Dusit Medical Services has market cap of $10.8B and EV of $11.1B.
Bangkok Dusit Medical Services's trades at 3.5x LTM EV/Revenue multiple, and 14.3x LTM EBITDA.
Analysts estimate Bangkok Dusit Medical Services's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Bangkok Dusit Medical Services and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $11.1B | XXX | XXX | XXX |
| EV/Revenue | 3.5x | XXX | XXX | XXX |
| EV/EBITDA | 14.1x | XXX | XXX | XXX |
| P/E | 23.1x | XXX | XXX | XXX |
| P/E/Growth | 3.0x | XXX | XXX | XXX |
| EV/FCF | 33.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpBangkok Dusit Medical Services's NTM/LTM revenue growth is 7%
Bangkok Dusit Medical Services's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $10K for the same period.
Over next 12 months, Bangkok Dusit Medical Services's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Bangkok Dusit Medical Services's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Bangkok Dusit Medical Services and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 7% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 7% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 32% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $10K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 19% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 18% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Compass Pathways | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Bangkok Dusit Medical Services acquired XXX companies to date.
Last acquisition by Bangkok Dusit Medical Services was XXXXXXXX, XXXXX XXXXX XXXXXX . Bangkok Dusit Medical Services acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Bangkok Dusit Medical Services founded? | Bangkok Dusit Medical Services was founded in 1969. |
| Where is Bangkok Dusit Medical Services headquartered? | Bangkok Dusit Medical Services is headquartered in Thailand. |
| How many employees does Bangkok Dusit Medical Services have? | As of today, Bangkok Dusit Medical Services has 56.0K+ employees. |
| Who is the CEO of Bangkok Dusit Medical Services? | Bangkok Dusit Medical Services's CEO is Dr. Poramaporn Prasarttong-Osoth, M.D.. |
| Is Bangkok Dusit Medical Services publicy listed? | Yes, Bangkok Dusit Medical Services is a public company listed on BKK. |
| What is the stock symbol of Bangkok Dusit Medical Services? | Bangkok Dusit Medical Services trades under BDMS ticker. |
| When did Bangkok Dusit Medical Services go public? | Bangkok Dusit Medical Services went public in 1991. |
| Who are competitors of Bangkok Dusit Medical Services? | Similar companies to Bangkok Dusit Medical Services include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Bangkok Dusit Medical Services? | Bangkok Dusit Medical Services's current market cap is $10.8B |
| What is the current revenue of Bangkok Dusit Medical Services? | Bangkok Dusit Medical Services's last 12-month revenue is $3.2B. |
| What is the current EBITDA of Bangkok Dusit Medical Services? | Bangkok Dusit Medical Services's last 12-month EBITDA is $777M. |
| What is the current EV/Revenue multiple of Bangkok Dusit Medical Services? | Current revenue multiple of Bangkok Dusit Medical Services is 3.5x. |
| What is the current EV/EBITDA multiple of Bangkok Dusit Medical Services? | Current EBITDA multiple of Bangkok Dusit Medical Services is 14.3x. |
| What is the current revenue growth of Bangkok Dusit Medical Services? | Bangkok Dusit Medical Services revenue growth between 2023 and 2024 was 7%. |
| Is Bangkok Dusit Medical Services profitable? | Yes, Bangkok Dusit Medical Services is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
